CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2023		12,241,925
Beginning Balance at Dec. 31, 2023	$ 96,281	$ 122	$ (901)	$ 54,450	$ 42,196	$ 414
Treasury Stock, Beginning Balance (in shares) at Dec. 31, 2023			75,758
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) earnings	662				662
Other comprehensive earnings (loss)	(103)					(103)
Amortization of deferred compensation related to stock-based awards	349			349
Issuance of shares in connection with acquisition of Alfamation (in shares)		187,432
Issuance of shares in connection with acquisition of Alfamation	2,086	$ 2		2,084
Issuance of unvested shares of restricted stock (in shares)		138,838
Issuance of unvested shares of restricted stock	0	$ 1		(1)
Forfeiture of unvested shares of restricted stock (in shares)		(11,200)
Stock options exercised (in shares)		4,925
Stock options exercised	18			18
Shares issued under Employee Stock Purchase Plan (in shares)		4,104
Total cost of shares	54			54
Shares surrendered by employees to satisfy tax liability at vesting of stock-based awards (in shares)			2,757
Shares surrendered by employees to satisfy tax liability at vesting of stock-based awards	(30)		$ (30)
Ending Balance (in shares) at Mar. 31, 2024		12,566,024
Ending Balance at Mar. 31, 2024	$ 99,317	$ 125	$ (931)	56,954	42,858	311
Treasury Stock, Ending Balance (in shares) at Mar. 31, 2024			78,515
Beginning Balance (in shares) at Dec. 31, 2024	12,457,658	12,457,658
Beginning Balance at Dec. 31, 2024	$ 99,790	$ 124	$ (942)	57,658	45,087	(2,137)
Treasury Stock, Beginning Balance (in shares) at Dec. 31, 2024	79,382		79,382
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) earnings	$ (2,329)				(2,329)
Other comprehensive earnings (loss)	1,462					1,462
Amortization of deferred compensation related to stock-based awards	423			423
Issuance of unvested shares of restricted stock (in shares)		134,196
Issuance of unvested shares of restricted stock	$ 0	$ 1		(1)
Forfeiture of unvested shares of restricted stock (in shares)		(27,365)
Stock options exercised (in shares)	4,925	4,925
Stock options exercised	$ 18			18
Shares issued under Employee Stock Purchase Plan (in shares)		5,374
Total cost of shares	36			36
Shares surrendered by employees to satisfy tax liability at vesting of stock-based awards (in shares)			646
Shares surrendered by employees to satisfy tax liability at vesting of stock-based awards	$ (5)		$ (5)
Ending Balance (in shares) at Mar. 31, 2025	12,574,788	12,574,788
Ending Balance at Mar. 31, 2025	$ 99,395	$ 125	$ (947)	$ 58,134	$ 42,758	$ (675)
Treasury Stock, Ending Balance (in shares) at Mar. 31, 2025	80,028		80,028